Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | APUR Aperture AC | 13G | 7.8% | Jun 30, 2026 | 3mo |
| Alyeska Investment Group, L.P. | SPWR SunPower Inc. | 13G/A | 4.73% | Jun 30, 2026 | 3mo |
| Capital Ventures International | LAZRQ Luminar Technologies, Inc. | 13G/A | 0% | Jun 30, 2026 | 3mo |
| MMCAP International Inc. SPC | ZONE Zone Frontier Inc. | 13G/A | 6.3% | Jun 30, 2026 | 3mo |
| Manulife Investment Management (US) LLC | CZWI Citizens Community Bancorp Inc. | 13G/A | 4.96% | Jun 30, 2026 | 3mo |
| ADAR1 Capital Management, LLC | KPRX Kiora Pharmaceuticals Inc | 13G/A | 9.9% | Jun 30, 2026 | 3mo |
| Harraden Circle Investments, LLC | CCII Cohen Circle Acquisition Corp. II | 13G/A | 7.21% | Jun 30, 2026 | 3mo |
| T. Rowe Price Investment Management, Inc. | CABA Cabaletta Bio, Inc. | 13G/A | 11.6% | Jun 30, 2026 | 3mo |
| MMCAP International Inc. SPC | PLRZ Polyrizon Ltd. | 13G/A | 9.6% | Jun 30, 2026 | 3mo |
| METEORA CAPITAL, LLC | CCIX Churchill Capital Corp IX | 13G | 6.33% | Jun 30, 2026 | 3mo |
| ARK Investment Management LLC | TXG 10x Genomics, Inc. | 13G/A | 8.56% | Jun 30, 2026 | 3mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | CLDX Celldex Therapeutics, Inc. | 13G | 6% | Jun 30, 2026 | 3mo |
| Fourthstone LLC | PKBK Parke Bancorp, Inc. | 13G/A | 0% | Jun 30, 2026 | 3mo |
| Balyasny Asset Management L.P. | OVID Ovid Therapeutics Inc. | 13G/A | 4.99% | Jun 30, 2026 | 3mo |
| Encompass Capital Advisors LLC | EROK EagleRock Land, LLC | 13G/A | 7.6% | Jun 30, 2026 | 3mo |
| CastleKnight Master Fund LP | HAIN Hain Celestial Group Inc | 13G/A | 9.97% | Jun 30, 2026 | 3mo |
| COHEN & STEERS, INC. | ELS Equity Lifestyle Properties Inc | 13G/A | 7.68% | Jun 30, 2026 | 3mo |
| GOLDMAN SACHS GROUP INC | FORL Four Leaf Acquisition Corporation Class A Common Stock | 13G/A | 0% | Jun 30, 2026 | 3mo |
| Commodore Capital LP | DFTX Definium Therapeutics, Inc. | 13G/A | 1.8% | Jun 30, 2026 | 3mo |
| METEORA CAPITAL, LLC | RAC Rithm Acquisition Corp. | 13G/A | 6.03% | Jun 30, 2026 | 3mo |
| Key Group Long Term Investments LP | CHRD Chord Energy Corp | 13G/A | 3.2% | Jun 30, 2026 | 3mo |
| GMT Capital Corp | CBRL Cracker Barrel Old Country Store, Inc | 13G/A | 2.44% | Jun 30, 2026 | 3mo |
| EVENTIDE ASSET MANAGEMENT, LLC | OVID Ovid Therapeutics Inc. | 13G/A | 6.3% | Jun 30, 2026 | 3mo |
| Anson Funds Management LP | XXII 22nd Century Group, Inc. | 13G/A | 6.7% | Jun 30, 2026 | 3mo |
| Sculptor Capital LP | ATLQ Atlantic Acquisition Corp I | 13G/A | 0% | Jun 30, 2026 | 3mo |
| BAMCO INC /NY/ | CHH Choice Hotels International Inc | 13G/A | 20.5% | Jun 30, 2026 | 3mo |
| Polar Asset Management Partners Inc. | OHAC Oceanhawk Acquisition Corp. | 13G | 5% | Jun 30, 2026 | 3mo |
| RA CAPITAL MANAGEMENT, L.P. | CRVO CervoMed Inc. | 13G/A | 8.6% | Jun 30, 2026 | 3mo |
| PERCEPTIVE ADVISORS LLC | STRO Sutro Biopharma, Inc. | 13G/A | 7.9% | Jun 30, 2026 | 3mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | FRNM Freenome, Inc. | 13G | 0% | Jun 30, 2026 | 3mo |
| AuGC BioFund LP | PTN Palatin Technologies Inc | 13G/A | 4.7% | Jun 30, 2026 | 3mo |
| ADAR1 Capital Management, LLC | YARW Yarrow Bioscience, Inc. | 13G | 8.8% | Jun 30, 2026 | 3mo |
| Balyasny Asset Management L.P. | CTNM Contineum Therapeutics, Inc. | 13G/A | 7.14% | Jun 30, 2026 | 3mo |
| MMCAP International Inc. SPC | POET Poet Technologies Inc. | 13G/A | 9.99% | Jun 30, 2026 | 3mo |
| Polar Asset Management Partners Inc. | TONT Graf Global Corp. | 13G | 5.6% | Jun 30, 2026 | 3mo |
| FULLER & THALER ASSET MANAGEMENT, INC. | ICUI Icu Medical Inc | 13G/A | 5.19% | Jun 30, 2026 | 3mo |
| Woodline Partners LP | TNGX Tango Therapeutics, Inc. | 13G/A | 2.5% | Jun 30, 2026 | 3mo |
| Polar Capital Holdings Plc | ARQT Arcutis Biotherapeutics, Inc. | 13G | 5.28% | Jun 30, 2026 | 3mo |
| RA CAPITAL MANAGEMENT, L.P. | TSHA Taysha Gene Therapies, Inc. | 13G/A | 9.9% | Jun 30, 2026 | 3mo |
| ARMISTICE CAPITAL, LLC | KYNB Kyntra Bio, Inc. | 13G/A | 9.88% | Jun 30, 2026 | 3mo |
| CITADEL ADVISORS LLC | MNTS Momentus Inc. | 13G/A | 1.6% | Jun 30, 2026 | 3mo |
| Divisadero Street Capital Management, LP | DAVE Dave Inc. | 13G/A | 6.1% | Jun 30, 2026 | 3mo |
| Richard F. Bunch III | TWFG TWFG, Inc. | 13G/A | 0.7% | Jun 30, 2026 | 3mo |
| GOLDMAN SACHS GROUP INC | TNGX Tango Therapeutics, Inc. | 13G | 6% | Jun 30, 2026 | 3mo |
| BAMCO INC /NY/ | FDS Factset Research Systems Inc | 13G/A | 11.81% | Jun 30, 2026 | 3mo |
| T. Rowe Price Investment Management, Inc. | SVV Savers Value Village, Inc. | 13G/A | 4.8% | Jun 30, 2026 | 3mo |
| CANADA PENSION PLAN INVESTMENT BOARD | COLD Americold Realty Trust | 13G/A | 2.8% | Jun 30, 2026 | 3mo |
| RA CAPITAL MANAGEMENT, L.P. | ACRS Aclaris Therapeutics, Inc. | 13G/A | 9.1% | Jun 30, 2026 | 3mo |
| ALLIANCEBERNSTEIN L.P. | ATRC AtriCure, Inc. | 13G/A | 5.5% | Jun 30, 2026 | 3mo |
| G1 Execution Services, LLC | NUAI New ERA Energy & Digital, Inc. | 13G/A | 4.2% | Jun 30, 2026 | 3mo |